Please login to the form below

Not currently logged in
Email:
Password:

Brexit

This page shows the latest Brexit news and features for those working in and with pharma, biotech and healthcare.

MHRA outlines two-year delivery plan with ‘patient first’ focus

MHRA outlines two-year delivery plan with ‘patient first’ focus

New delivery plan also outlines strategy for UK regulatory body following Brexit.

Latest news

More from news
Approximately 172 fully matching, plus 79 partially matching documents found.

Latest Intelligence

  • Setting up for success in a post-Brexit, post-pandemic Britain Setting up for success in a post-Brexit, post-pandemic Britain

    the prospect of Brexit has done little to dampen confidence in this sector. ... Dealing with Brexit. Brexit has, and will continue to have, a significant impact on the pharmaceutical and healthcare sector.

  • A new era for UK-Japanese scientific research relations A new era for UK-Japanese scientific research relations

    This denotes the strategic importance that the UK government gives to the region as it finds its feet in a post-Brexit world. ... This role has increased since Brexit and can be critical in delivering the fastest and most effective trials.

  • Rare genetic diseases – what’s in store for 2021? Rare genetic diseases – what’s in store for 2021?

    In the UK, the looming Brexit sparked new models of regulatory approval and fast-track opportunities, as recently observed in the rapid approval of Pfizer’s COVID-19 vaccine. ... However, with the Brexit transition, those in the healthcare industry are

  • The Brexit clock is counting down and time is running out The Brexit clock is counting down and time is running out

    What businesses need to know about post-Brexit immigration. With only weeks now until the Brexit transition period ends on 31 December 2020, businesses are running out of time to prepare ... Top tips for employers – EU Settlement Scheme. If not already

  • A snapshot of… Exscientia A snapshot of… Exscientia

    What impact is the planned Brexit having on the company? For Exscientia, access to great talent is vital.

More from intelligence
Approximately 20 fully matching, plus 49 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 14 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

The biggest problems facing humanity today are health-related, and the health of people, animals and our planet are inextricably linked. ...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...